QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 18,360
0.00 (0.00%)
At close: Feb 19, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 200.18 billion as of February 20, 2026.
Market Cap
200.18B
Enterprise Value
203.27B
Revenue
13.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
18,360.00
Market Cap Chart
Since December 12, 2025, QuadMedicine's market cap has increased from 199.95B to 200.18B, an increase of 0.11%. That is a compound annual growth rate of 0.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 200.18B | 13.21% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 256.46B |
| ISU Abxis | 226.00B |
| Vaxcell-Bio Therapeutics | 220.71B |
| Prestige Biologics | 219.65B |
| Bio Solution | 214.17B |
| Kangstem Biotech | 206.45B |
| Ensol Biosciences | 201.99B |
| TiumBio | 181.16B |